DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Companyâs robust platform delivers kidney care services and includes established nephrology and payor relationships. The Companyâs international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Companyâs U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
äŒæ¥ã³ãŒãDVA
äŒç€ŸåDaVita Inc
äžå Žæ¥Oct 31, 1995
æé«çµå¶è²¬ä»»è
ãCEOãRodriguez (Javier J)
åŸæ¥å¡æ°76000
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Oct 31
æ¬ç€Ÿæåšå°2000 16th St
éœåžDENVER
蚌åžååŒæNASDAQ OMX NASDAQ Basic NYSE
åœUnited States of America
éµäŸ¿çªå·80202-5117
é»è©±çªå·13105362668
ãŠã§ããµã€ãhttps://www.davita.com/
äŒæ¥ã³ãŒãDVA
äžå Žæ¥Oct 31, 1995
æé«çµå¶è²¬ä»»è
ãCEOãRodriguez (Javier J)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã